Cabanillas, Maria E <br/><br/>
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Jun 2010 
 - 2588-95 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2009-1923  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Benzenesulfonates--administration & dosage<br/>DNA Mutational Analysis<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Niacinamide--analogs & derivatives<br/>Off-Label Use<br/>Phenylurea Compounds<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyridines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Sorafenib<br/>Sunitinib<br/>Survival Analysis<br/>Thyroglobulin--blood<br/>Thyroid Neoplasms--diagnostic imaging<br/>Tomography, X-Ray Computed<br/>Treatment Outcome